Vaxfab Enterprises Ltd

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.51.5, marking a significant milestone in its trading journey. This new peak reflects strong momentum as the stock continues its upward trajectory, outperforming its sector and demonstrating robust gains over the past year.

Vaxfab Enterprises Ltd, a key player in the Trading & Distributors sector, reached a significant milestone today by hitting a new 52-week high of Rs.50.25. This achievement underscores the stock’s robust momentum, driven by sustained gains over the past week and strong market positioning despite broader index declines.

Vaxfab Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date view of its performance and prospects.

Vaxfab Enterprises Ltd, a key player in the Trading & Distributors sector, reached a significant milestone today by hitting a new 52-week high of Rs.49.65. This achievement marks a continuation of the stock’s robust momentum, reflecting strong market performance over the past year and a notable surge in recent trading sessions.

Vaxfab Enterprises Ltd, a key player in the Trading & Distributors sector, has surged to a fresh 52-week high of Rs.49.2, marking a significant milestone in its stock performance. This new peak reflects robust momentum driven by sustained gains and favourable market conditions.

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.48.84, marking a significant milestone in its trading journey. This new peak reflects strong momentum as the stock continues to outperform its sector and broader market indices.

Vaxfab Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 October 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 15 January 2026, providing investors with the latest insights into its performance and outlook.

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.47.06, marking a significant milestone in its trading journey. This new peak reflects sustained momentum, with the stock outperforming its sector and demonstrating robust gains over the past several sessions.

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.45.59, marking a significant milestone in its stock performance. This new peak reflects sustained momentum driven by robust gains over the past eight trading sessions, outpacing its sector and broader market indices.

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.43.92, marking a significant milestone in its trading journey. The stock’s sustained momentum over the past week has propelled it well above key moving averages, reflecting robust performance within the Trading & Distributors sector.

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.43.92, marking a significant milestone in its trading journey. This achievement reflects sustained momentum, with the stock outperforming its sector and demonstrating robust gains over the past week.

Vaxfab Enterprises Ltd has surged to a fresh 52-week high of Rs.43.51, marking a significant milestone in its trading journey. This new peak reflects robust momentum as the stock outperformed its sector and sustained a strong upward trajectory over recent sessions.

Vaxfab Enterprises Ltd, a key player in the Trading & Distributors sector, reached a significant milestone today by hitting a new 52-week high of Rs.40. This achievement marks a continuation of the stock’s robust upward momentum, reflecting sustained gains over recent sessions and outperforming its sector peers.

Vaxfab Enterprises Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 23 October 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date perspective on the company’s performance and outlook.